The Journal of Clinical Psychiatry

Please take our online poll

Close [X]

Online Poll

Please answer the following questions to help us meet your needs.

1. How confident are you in your ability to treat patients with suicidal thoughts or behaviors?

Not at all

Somewhat

Moderately

Very

Extremely

2. How familiar are you with the Columbia-Suicide Severity Rating Scale (C-SSRS)?

Not at all

Somewhat

Moderately

Very

Extremely

3. How often do you use the C-SSRS to assess your patients with suicidal thoughts or behaviors?

Never

Rarely

Sometimes

Most of the time

All of the time

Psychiatrist.com
The Journal of Clinical Psychiatry
CME Institute | MedFair.com
The Primary Care Companion

Psychiatrist.com Home    Keyword Search

Close [X]

Search Our Sites

Enter search terms below (keywords, titles, authors, or subjects). Then select a category to search and press the Search button. All words are assumed to be required. To search for an exact phrase, put it in quotes. To exclude a term, precede it with a minus sign (-).

Keyword search:

Choose a category:

Choosing the appropriate category will greatly improve your chances of finding the best match.

All files at our sites: J Clin Psychiatry, Primary Care Companion, CME Institute, and MedFair

Search materials from our journals:

Abstracts from The Journal of Clinical Psychiatry, 1996–present, both regular issues and supplements

PDFs of the full text of The Journal of Clinical Psychiatry, 1996–present, both regular issues and supplements (paid subscribers)

PDFs of the full text of The Primary Care Companion, 1999–present

Search CME offerings:

CME Institute, including CME from journals , supplements, and Web activities for instant CME credit (registered users); also includes information about our CME program

CME activities from regular issues of The Journal of Clinical Psychiatry (registered users)

CME Supplements from The Journal of Clinical Psychiatry (registered users)
Psychiatrist.com The Journal of Clinical Psychiatry The Primary Care Companion for CNS Disorders The CME Institute Neurology Knowledge Terms of Use Privacy Policy

Now @ JCP

Ahead of Print
Current Issue
Forum
Most Popular

Journal Archive

Worried About Insomnia?
Paul King, MD

Is it possible to achieve enough worry to be productive but not have it get so out of control that it leads to insomnia? Any suggestions?

» Read this post

» Read the entire blog

Managing Comorbidities in Severe Mental Illness Roger S. McIntyre, MD, FRCPC (Chair), et al

Learn about implementing treatment strategies to address modifiable health risk factors in your patients.

>>See the entire activity

The Use of MAOIs in Primary Care Larry Culpepper, MD, MPH

New! Read about the safety, tolerability, and efficacy of MAOIs, and find out which of your primary care patients may best respond to these agents.

>>See the entire activity

Now @
JCP

Journal
Archive

Collections

Education

Authors &
Reviewers

Ahead of Print
Current Issue
Forums

View full page

Articles published electronically 2/21/12

Risks for the Transition From Major Depressive Disorder to Bipolar Disorder in the National Epidemiologic Survey on Alcohol and Related Conditions

Stephen E. Gilman, Jamie M. Dupuy, and Roy H. Perlis

[Abstract] [Full Text] Posted 2/21/12

Evaluation of the Glycine Transporter Inhibitor Org 25935 as Augmentation to Cognitive-Behavioral Therapy for Panic Disorder: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

Kari R. Nations, Jasper A. J. Smits, David F. Tolin, Barbara O. Rothbaum, Stefan G. Hofmann, Candyce D. Tart, Allen Lee, Jacques Schipper, Magnus Sjogren, Dixi Xue, Armin Szegedi, and Michael W. Otto

[Abstract] [Full Text] Posted 2/21/12

Statin Use and Risk of Depression in Patients With Coronary Heart Disease: Longitudinal Data From the Heart and Soul Study

Christian Otte, Shoujun Zhao, and Mary A. Whooley

[Abstract] [Full Text] Posted 2/21/12

Brain-Volume Increase With Sustained Remission in Patients With Treatment-Resistant Unipolar Depression

Jennifer L. Phillips, Lisa A. Batten, Fahad Aldosary, Philippe Tremblay, and Pierre Blier

[Abstract] [Full Text] Posted 2/21/12

Continued Cannabis Use and Outcome in First-Episode Psychosis: Data From a Randomized, Open-Label, Controlled Trial

Gunnar Faber, Henderikus G. O. M. Smid, Arthur R. Van Gool, Lex Wunderink, Robert J. van den Bosch, and Durk Wiersma

[Abstract] [Full Text] Posted 2/21/12

Articles published electronically 2/7/12

Neural and Behavioral Correlates of Peritraumatic Dissociation in an Acutely Traumatized Sample

Judith K. Daniels, Nick J. Coupland, Kathy M. Hegadoren, Brian H. Rowe, Maria Densmore, Richard W. J. Neufeld, and Ruth A. Lanius

[Abstract] [Full Text] Posted 2/7/12

Articles published electronically 1/24/12

Impact of Deleting 5 DSM-IV Personality Disorders on Prevalence, Comorbidity, and the Association Between Personality Disorder Pathology and Psychosocial Morbidity

Mark Zimmerman, Iwona Chelminski, Diane Young, Kristy Dalrymple, and Jennifer Martinez

[Abstract] [Full Text] Posted 1/24/12 [Related Blog Post] FREE to registered users

Articles published electronically 1/10/12

An 8-Week, Randomized Controlled Trial of Atomoxetine, Atomoxetine Plus Buspirone, or Placebo in Adults With ADHD

Suzanne M. Sutherland, Lenard A. Adler, Crystal Chen, Michael D. Smith, and Douglas E. Feltner

[Abstract] [Full Text] Posted 1/10/12

Poor Sleep at Baseline Predicts Worse Mood Outcomes in Patients With Co-Occurring Bipolar Disorder and Substance Dependence

Susan I. Putnins, Margaret L. Griffin, Garrett M. Fitzmaurice, Dorian R. Dodd, and Roger D. Weiss

[Abstract] [Full Text] Posted 1/10/12

Lifespan Persistence of ADHD: The Life Transition Model and Its Application

Atilla Turgay, David W. Goodman, Philip Asherson, Robert A. Lasser, Thomas F. Babcock, Michael L. Pucci, and Russell Barkley

[Abstract] [Full Text] Posted 1/10/12

Articles published electronically 12/27/11

Prediabetes in Patients Treated With Antipsychotic Drugs

Peter Manu, Christoph U. Correll, Ruud van Winkel, Martien Wampers, and Marc De Hert

[Abstract] [Full Text] Posted 12/27/11

Comparison of Women With Confirmed Versus Presumably Misdiagnosed Bipolar Disorder

D. Jeffrey Newport, Ross J. Baldessarini, Bettina T. Knight, Susana V. Fernandez, Natalie J. Morris, Adele C. Viguera, and Zachary N. Stowe

[Abstract] [Full Text] Posted 12/27/11

Can People With Nonsevere Major Depression Benefit From Antidepressant Medication?

Jessica A. Stewart, Deborah A. Deliyannides, David J. Hellerstein, Patrick J. McGrath, and Jonathan W. Stewart

[Abstract] [Full Text] Posted 12/27/11

Suicidal Risk Factors in Bipolar I and II Disorder Patients

Juan Undurraga, Ross J. Baldessarini, Marc Valenti, Isabella Pacchiarotti, and Eduard Vieta

[Abstract] [Full Text] Posted 12/27/11

Articles published electronically 12/13/11

The Impact of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) on Prescribing Practices: An Analysis of Data From a Large Midwestern State

Rachel L. Berkowitz, Urvashi Patel, Quanhong Ni, Joseph J. Parks, and John P. Docherty

[Abstract] [Full Text] Posted 12/13/11

Nonsteroidal Anti-Inflammatory Drugs in Schizophrenia: Ready for Practice or a Good Start? A Meta-Analysis

Iris E. Sommer, Lot de Witte, Marieke Begemann, and René S. Kahn

[Abstract] [Full Text] Posted 12/13/11

Articles published electronically 11/29/11

Insomnia and Objectively Measured Sleep Disturbances Predict Treatment Outcome in Depressed Patients Treated With Psychotherapy or Psychotherapy-Pharmacotherapy Combinations

Wendy M. Troxel, David J. Kupfer, Charles F. Reynolds III, Ellen Frank, Michael E. Thase, Jean M. Miewald, and Daniel J. Buysse

[Abstract] [Full Text] Posted 11/29/11

The Relationships of Environment and Personal Characteristics to Agitated Behaviors in Nursing Home Residents With Dementia

Jiska Cohen-Mansfield, Khin Thein, Marcia S. Marx, Maha Dakheel-Ali, Havi Murad, and Laurence S. Freedman

[Abstract] [Full Text] Posted 11/29/11

Maternal Depression and Anxiety Differentially Impact Fetal Exposures During Pregnancy

D. Jeffrey Newport, Shuang Ji, Qi Long, Bettina T. Knight, Elizabeth B. Zach, Elizabeth N. Smith, Natalie J. Morris, and Zachary N. Stowe

[Abstract] [Full Text] Posted 11/29/11

Declining Benzodiazepine Use in Veterans With Posttraumatic Stress Disorder

Brian C. Lund, Nancy C. Bernardy, Bruce Alexander, and Matthew J. Friedman

[Abstract] [Full Text] Posted 11/29/11

Articles published electronically 11/15/11

Gene-Temperament Interactions Might Distinguish Between Bipolar I and Bipolar II Disorders: A Cross-Sectional Survey of Han Chinese in Taiwan

Yi-Ann Lu, Sheng-Yu Lee, Shiou-Lan Chen, Shih-Heng Chen, Chun-Hsien Chu, Nian-Sheng Tzeng, San-Yuan Huang, Po-Hsiu Kuo, Chen-Lin Wang, I Hui Lee, Tzung Lieh Yeh, Yen Kuang Yang, and Ru-Band Lu

[Abstract] [Full Text] Posted 11/15/11

Articles published electronically 11/1/11

Trauma at the Hands of Another: Longitudinal Study of Differences in the Posttraumatic Stress Disorder Symptom Profile Following Interpersonal Compared With Noninterpersonal Trauma

David Forbes, Susan Fletcher, Ruth Parslow, Andrea Phelps, Meaghan O’Donnell, Richard A. Bryant, Alexander McFarlane, Derrick Silove, and Mark Creamer

[Abstract] [Full Text] Posted 11/1/11

Understanding the Central Pharmacokinetics of Spheroidal Oral Drug Absorption System (SODAS) Dexmethylphenidate: A Positron Emission Tomography Study of Dopamine Transporter Receptor Occupancy Measured With C-11 Altropane

Thomas J. Spencer, Ali A. Bonab, Darin D. Dougherty, Tara Mirto, Jessica Martin, Allison Clarke, and Alan J. Fischman

[Abstract] [Full Text] Posted 11/1/11

How Informative Are Open-Label Studies for Youth With Bipolar Disorder? A Meta-Analysis Comparing Open-Label Versus Randomized, Placebo-Controlled Clinical Trials

Joseph Biederman, Carter R. Petty, K. Yvonne Woodworth, Alexandra Lomedico, Katherine B. O’Connor, Janet Wozniak, and Stephen V. Faraone

[Abstract] [Full Text] Posted 11/1/11

Emotional Numbing in Posttraumatic Stress Disorder: A Functional Magnetic Resonance Imaging Study

Paul A. Frewen, David J. A. Dozois, Richard W. J. Neufeld, Richard D. Lane, Maria Densmore, Todd K. Stevens, and Ruth A. Lanius

[Abstract] [Full Text] Posted 11/1/11

Web-Based Assessment of Depression in Patients Treated in Clinical Practice: Reliability, Validity, and Patient Acceptance

Mark Zimmerman and Jennifer H. Martinez

[Abstract] [Full Text] Posted 11/1/11

Mortality of Neuroleptic Malignant Syndrome Induced by Typical and Atypical Antipsychotic Drugs: A Propensity-Matched Analysis From the Japanese Diagnosis Procedure Combination Database

Mitsuhiro Nakamura, Hideo Yasunaga, Hiroaki Miyata, Takafumi Shimada, Hiromasa Horiguchi, and Shinya Matsuda

[Abstract] [Full Text] Posted 11/1/11

Articles published electronically 10/18/11

Gender, HIV Status, and Psychiatric Disorders: Results From the National Epidemiologic Survey on Alcohol and Related Conditions

Mariana Lopes, Mark Olfson, Judith Rabkin, Deborah S. Hasin, Analucía A. Alegría, Keng-Han Lin, Bridget F. Grant, and Carlos Blanco

[Abstract] [Full Text] Posted 10/18/11

ARVCF Genetic Influences on Neurocognitive and Neuroanatomical Intermediate Phenotypes in Chinese Patients With Schizophrenia

Kang Sim, Wai-Yen Chan, Puay-San Woon, Hui-Qi Low, Linda Lim, Guo-Liang Yang, Jimmy Lee, Siow Ann Chong, Yih-Yian Sitoh, Yiong Huak Chan, Jianjun Liu, Ene Choo Tan, Hywel Williams, and Wieslaw Lucjan Nowinski

[Abstract] [Full Text] Posted 10/18/11

The Relation of Serotonin-Related Gene and COMT Gene Polymorphisms With Criminal Behavior in Schizophrenic Disorder

Kyung Bong Koh, Eun Hee Choi, Young-joon Lee, Mooyoung Han, Sang-Sup Choi, So Won Kim, and Min Goo Lee

[Abstract] [Full Text] Posted 10/18/11

Articles published electronically 10/4/11

Early Response and Remission as Predictors of a Good Outcome of a Major Depressive Episode at 12-Month Follow-Up: A Prospective, Longitudinal, Observational Study

Antonio Ciudad, Enrique Álvarez, Miquel Roca, Enrique Baca, Luis Caballero, Pepa García de Polavieja, Marta Casillas, Amparo Valladares, and Inmaculada Gilaberte

[Abstract] [Full Text] Posted 10/4/11

Insomnia as a Risk for Depression: A Longitudinal Epidemiologic Study on a Japanese Rural Cohort

Isa Okajima, Yoko Komada, Takashi Nomura, Kenji Nakashima, and Yuichi Inoue

[Abstract] [Full Text] Posted 10/4/11

Articles published electronically 9/20/11

Efficacy of Dose Increase Among Nonresponders to Low-Dose Aripiprazole Augmentation in Patients With Inadequate Response to Antidepressant Treatment: A Randomized, Double-Blind, Placebo-Controlled, Efficacy Trial

David Mischoulon, Janet Witte, Michael Levy, George I. Papakostas, L. Russell Pet, Wen-hua Hsieh, Michael J. Pencina, Sean Ward, Mark H. Pollack, and Maurizio Fava

[Abstract] [Full Text] Posted 9/20/11

Articles published electronically 9/6/11

Epidemiology of Major Depression With Atypical Features: Results From the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC)

Carlos Blanco, Oriana Vesga-López, Jonathan W. Stewart, Shang-Min Liu, Bridget F. Grant, and Deborah S. Hasin

[Abstract] [Full Text] Posted 9/6/11

Neural Correlates and Predictive Power of Trait Resilience in an Acutely Traumatized Sample: A Pilot Investigation

Judith K. Daniels, Kathy M. Hegadoren, Nick J. Coupland, Brian H. Rowe, Maria Densmore, Richard W. J. Neufeld, and Ruth A. Lanius

[Abstract] [Full Text] Posted 9/6/11

Articles published electronically 8/23/11

Predictors of Psychiatric Inpatient Suicide: A National Prospective Register-Based Study

Trine Madsen, Esben Agerbo, Preben B. Mortensen, and Merete Nordentoft

[Abstract] [Full Text] Posted 8/23/11

Bereavement and the Diagnosis of Major Depressive Episode in the National Epidemiologic Survey on Alcohol and Related Conditions

Stephen E. Gilman, Joshua Breslau, Nhi-Ha Trinh, Maurizio Fava, Jane M. Murphy, and Jordan W. Smoller

[Abstract] [Full Text] Posted 8/23/11

Retinoic Acid and Affective Disorders: The Evidence for an Association

J. Douglas Bremner, Kirsty D. Shearer, and Peter J. McCaffery

[Abstract] [Full Text] Posted 8/23/11

Articles published electronically 8/9/11

Successful Pharmacologic Treatment of Major Depressive Disorder Attenuates Amygdala Activation to Negative Facial Expressions: A Functional Magnetic Resonance Imaging Study

Henricus G. Ruhé, Jan Booij, Dick J. Veltman, Martin C. Michel, and Aart H. Schene

[Abstract] [Full Text] Posted 8/9/11

The Clinical Process in Psychiatry: A Clinimetric Approach

Giovanni A. Fava, Chiara Rafanelli, and Elena Tomba

[Abstract] [Full Text] Posted 8/9/11

Articles published electronically 7/12/11

Analysis of Gene Variants Previously Associated With Iloperidone Response in Patients With Schizophrenia Who Are Treated With Risperidone

Bonnie A. Fijal, Virginia L. Stauffer, Bruce J. Kinon, Robert R. Conley, Vicki Poole Hoffmann, Michael M. Witte, Fangyi Zhao, and John P. Houston

[Abstract] [Full Text] Posted 7/12/11

Articles published electronically 5/17/11

Assessment of Treatment Algorithms Including Amantadine, Metformin, and Zonisamide for the Prevention of Weight Gain With Olanzapine: A Randomized Controlled Open-Label Study

Vicki Poole Hoffmann, Michael Case, and Jennie G. Jacobson

[Abstract] [Full Text] Posted 5/17/11

Ahead of Print
Current Issue
Forums

View full page

Volume 73 • January 2012 • Number 1

Editorial

5 JCP’s Circle of Honor and Peer Reviewers

Alan J. Gelenberg and Marlene P. Freeman

[Abstract] [Full Text]

Commentaries

64 Questions Raised by the Failure of a Trial of Short-Term Psychodynamic Therapy Versus Pharmacotherapy for Major Depressive Disorder

James H. Kocsis

[Abstract] [Full Text]

113 Depression in Older Adults: Is There Another Reason to Worry?

Anton P. Porsteinsson and Kelly M. Makino

[Abstract] [Full Text]

Original Research

8 Does the Presence of One Feature of Borderline Personality Disorder Have Clinical Significance? Implications for Dimensional Ratings of Personality Disorders

Mark Zimmerman, Iwona Chelminski, Diane Young, Kristy Dalrymple, and Jennifer Martinez

[Abstract] [Full Text][Clinical Points]

Clinical Points
  • Low-severity levels of borderline personality disorder can be assessed reliably.
  • Psychiatric outpatients with 1 borderline personality disorder criterion have greater psychosocial morbidity than patients with 0 criteria.
  • The results support suggestions to rate borderline personality disorder dimensionally because low severity levels of such pathology are clinically significant.

[Close]

13 A Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Tolerability of High-Dose Quetiapine in Patients With Persistent Symptoms of Schizophrenia or Schizoaffective Disorder

William G. Honer, G. William MacEwan, Alain Gendron, Emmanuel Stip, Alain Labelle, Richard Williams, and Hans Eriksson for the STACK Study Group

[Abstract] [Full Text] [Clinical Points]

Clinical Points
  • Like other atypical antipsychotics, quetiapine is often prescribed at higher than approved doses for patients with schizophrenia or schizoaffective disorder.
  • While using quetiapine at doses greater than 800 mg/d does not increase extrapyramidal symptoms, weight gain is greater at higher than approved doses.
  • Higher than approved doses offer no additional benefit in improving symptom severity.

[Close]

31 Obstructive Sleep Apnea/Hypopnea Syndrome and Poor Response to Sertraline in Patients With Coronary Heart Disease

Annelieke M. Roest, Robert M. Carney, Phyllis K. Stein, Kenneth E. Freedland, Hilary Meyer, Brian C. Steinmeyer, Peter de Jonge, and Eugene H. Rubin

[Abstract] [Full Text] [Clinical Points]

Clinical Points
  • Depression and obstructive sleep apnea/hypopnea syndrome (OSAHS) are both associated with cardiac mortality in patients with heart disease.
  • Both depression and OSAHS are very common in patients with heart disease.
  • Untreated OSAHS is associated with a poor response to sertraline treatment in patients with heart disease and major depression.

[Close]

57 Double-Blind, Randomized, Placebo-Controlled Long-Term Maintenance Study of Aripiprazole in Children With Bipolar Disorder

Robert L. Findling, Eric A. Youngstrom, Nora K. McNamara, Robert J. Stansbrey, Jaime L. Wynbrandt, Clara Adegbite, Brieana M. Rowles, Christine A. Demeter, Thomas W. Frazier, and Joseph R. Calabrese

[Abstract] [Full Text] [Clinical Points]

Clinical Points
  • Prospective, randomized maintenance studies in pediatric patients with bipolar disorder are feasible.
  • Aripiprazole is generally well tolerated and may be beneficial in the long-term treatment of young children with bipolar disorder.

[Close]

66 Short-Term Dynamic Psychotherapy Versus Pharmacotherapy for Major Depressive Disorder: A Randomized, Placebo-Controlled Trial

Jacques P. Barber, Marna S. Barrett, Robert Gallop, Moira A. Rynn, and Karl Rickels

[Abstract] [Full Text] [Clinical Points]

Clinical Points
  • Among low-income, inner-city depressed patients, there is not much evidence supporting the efficacy of either pharmacotherapy or brief dynamic therapy in comparison with placebo.
  • There is some preliminary evidence that minority men improved more following dynamic therapy than following pharmacotherapy and placebo, whereas white men improved more following placebo than following other treatments.
  • Preliminary evidence also indicates that white women will improve more following pharmacotherapy or dynamic therapy than following placebo, whereas minority women improved similarly across treatments. Those results require replication.

[Close]

74 Executive Function Predicts Response to Antiaggression Treatment in Schizophrenia: A Randomized Controlled Trial

Menahem I. Krakowski and Pal Czobor

[Abstract] [Full Text] [Clinical Points]

Clinical Points
  • Executive function is an important predictor of response to antiaggression treatment in patients with schizophrenia.
  • It is possible to customize treatment of aggression on the basis of the patient’s level of executive functioning.
  • Clozapine has a unique antiaggression profile, resulting in decreased violence even in patients with poor executive function prior to treatment.

[Close]

81 Omega-3 for Bipolar Disorder: Meta-Analyses of Use in Mania and Bipolar Depression

Jerome Sarris, David Mischoulon, and Isaac Schweitzer

[Abstract] [Full Text] [Clinical Points]

Clinical Points
  • Current evidence supports omega-3 in adjunctive treatment of bipolar depression.
  • Current evidence, however, does not support omega-3 in the adjunctive treatment of bipolar mania.
  • Clinicians are advised to recommend increased dietary omega-3 or daily supplementation of approximately 1 g to 1.5 g of mixed EPA and DHA (higher ratio of EPA).

[Close]

87 Factors Associated With the Persistence and Onset of New Anxiety Disorders in Youth With Bipolar Spectrum Disorders

Regina Sala, David A. Axelson, Josefina Castro-Fornieles, Tina R. Goldstein, Benjamin I. Goldstein, Wonho Ha, Fangzi Liao, Mary Kay Gill, Satish Iyengar, Michael A. Strober, Shirley Yen, Heather Hower, Jeffrey I. Hunt, Daniel P. Dickstein, Neal D. Ryan, Martin B. Keller, and Boris Birmaher

[Abstract] [Full Text] [Clinical Points]

Clinical Points
  • Anxiety disorders in youth with bipolar disorder tended to persist, and a substantial proportion of subjects developed new anxiety disorders.
  • Different factors, including the presence of severe or multiple anxiety disorders, ongoing mood symptoms, and comorbid disorders, were associated with the persistence and the onset of anxiety disorders. Early identification of factors may enable the development of strategies for treatment and prevention of anxiety disorders in bipolar youth.
  • Randomized controlled trials are warranted to evaluate the efficacy and tolerability of pharmacologic and psychosocial treatments for youth with comorbid bipolar disorder and anxiety disorders.

[Close]

95 Bupropion Sustained Release Added to Group Support for Smoking Cessation in Schizophrenia: A New Randomized Trial and a Meta-Analysis

Elaine Weiner, M. Patricia Ball, Alison S. Buchholz, James M. Gold, A. Eden Evins, Robert P. McMahon, and Robert W. Buchanan

[Abstract] [Full Text]

103 Placebo-Controlled Adjunctive Trial of Pramipexole in Patients With Bipolar Disorder: Targeting Cognitive Dysfunction

Katherine E. Burdick, Raphael J. Braga, Charles U. Nnadi, Yaniv Shaya, Walter H. Stearns, and Anil K. Malhotra

[Abstract] [Full Text] [Clinical Points]

Clinical Points
  • Many patients with bipolar disorder suffer from disabling neurocognitive impairment, yet this symptom domain has not been a common target for treatment.
  • Formal neurocognitive assessment and thorough clinical evaluation will be important in determining which patients with bipolar disorder might optimally benefit from cognitive intervention.
  • Although preliminary, our data are promising and suggest that improving neurocognitive functioning in patients with bipolar illness is a feasible ambition. Future studies of pramipexole and other agents will be important in continuing efforts to enhance treatment outcome and quality of life.

[Close]

21 Pretest

CME Activity

29 Posttest

 

22 The Role of Psychomotor Activation in Discriminating Unipolar From Bipolar Disorders: A Classification-Tree Analysis

Giovanni B. Cassano, Paola Rucci, Antonella Benvenuti, Mario Miniati, Simona Calugi, Luca Maggi, Stefano Pini, David J. Kupfer, Mario Maj, Andrea Fagiolini, and Ellen Frank

[Abstract] [Full Text] [Clinical Points]

Clinical Points
  • Our results support the role of lifetime psychomotor activation, as assessed by the Mood Spectrum Self-Report instrument, as the best discriminator of bipolar disorder from unipolar disorder.
  • The mixed instability factor contributed to the discrimination of bipolar from unipolar disorder in patients with intermediate levels of psychomotor activation.
  • Elevated mood (the euphoria factor) contributed to discrimination of bipolar from unipolar disorder in patients with low psychomotor activation scores.
  • The suicidality factor further discriminated bipolar from unipolar disorder.

[Close]

Review Article

37 Retinoic Acid and Affective Disorders: The Evidence for an Association

J. Douglas Bremner, Kirsty D. Shearer, and Peter J. McCaffery

[Abstract] [Full Text]

Case Report

51 Making Lemonade Out of Lemons: A Case Report and Literature Review of External Pressure as an Intervention With Pregnant and Parenting Substance-Using Women

Katherine J. Davis and Kimberly A. Yonkers

[Abstract] [Full Text] [Clinical Points]

Clinical Points
  • Pregnant and postpartum women are frequently exposed to external pressure to not use substances. The way in which pressure is applied in clinical situations can potentially influence the trajectory of the woman’s addiction, as well as her motivation to seek treatment and get prenatal care.
  • Providers should use external pressure to encourage pregnant and postpartum substance users to enter treatment in a collaborative and supportive manner. Confrontational strategies are less likely to be effective in addressing addiction, especially in this unique population.
  • Some strategies include (1) acknowledging individual women’s needs; (2) building positive, respectful relationships with patients; and (3) providing a range of resources that address their specialized barriers to treatment entry.

[Close]

Focus on Alzheimer’s Disease and Related Disorders

115 Metabolism of Amyloid-β Protein May Be Affected in Depression

Hajime Baba, Yoshiyuki Nakano, Hitoshi Maeshima, Emi Satomura, Yohei Kita, Toshihito Suzuki, and Heii Arai

[Abstract] [Full Text] [Clinical Points]

Clinical Points
  • Changes in amyloid-β (Aβ) metabolism may be a biological factor in the transition from depression to Alzheimer’s disease (AD).
  • Clinicians should follow up even with younger patients with major depressive disorder (MDD) and consider them to be at high risk for AD.
  • Higher blood Aβ40/Aβ42 ratio in patients with MDD may be an index for future preventive therapy for AD, such as amyloid vaccination.

[Close]

121 Effect of Second-Generation Antipsychotics on Caregiver Burden in Alzheimer’s Disease

Somaia Mohamed, Robert Rosenheck, Constantine G. Lyketsos, Richard Kaczynski, David L. Sultzer, and Lon S. Schneider

[Abstract] [Full Text] [Clinical Points]

Clinical Points
  • Alzheimer’s disease (AD) imposes a severe burden on patients and their relatives, particularly those individuals directly responsible for patient care.
  • Psychiatric and behavioral symptoms are the main correlates of caregiver burden.
  • Among AD patients with symptoms of psychosis, agitation, or aggressive behavior, atypical antipsychotic medications may reduce agitation, suspiciousness, and psychosis enough to have significant, if small, impact on caregivers’ experience of burden.
  • Psychosocial interventions designed to improve patients’ quality of life, eg, through increased socialization and social interactions, are also important in reducing caregiver burden.

[Close]

Letter to the Editor

129 Propranolol, Traumatic Memories, and Amnesia: A Study of 36 Cases

Robin P. D. Menzies

[Purchase] [Full Text]

Book Reviews

131 Teaching Mindfulness: A Practical Guide for Clinicians and Educators

Judith R. Milner

[Purchase] [Full Text]

131 Clinical Manual of Couples and Family Therapy

Scott D. Haltzman

[Purchase] [Full Text]

132 Clinical Manual of Electroconvulsive Therapy

Rajesh R. Tampi

[Purchase] [Full Text]

132 Treating Child and Adolescent Depression

Alex Cogswell and David L. Kaye

[Purchase] [Full Text]

Psychiatrist.com Exclusives

Original Research

e134 The Course of Chronic Pain With and Without Psychiatric Disorders: A 6-Year Follow-Up Study From Childhood to Adolescence and Young Adulthood

Lidewij M. E. Knook, Jeroen G. Lijmer, Antoinette Y. Konijnenberg, Beatrijs Taminiau, and Herman van Engeland

[Abstract] [Full Text] [Clinical Points]

Clinical Points
  • Chronic pain in most children in pediatric care is not self-limiting and is often accompanied by psychiatric disorders when they grow up.
  • Psychiatric care alongside standard medical care should be made available for children with chronic pain and impairing comorbid psychiatric disorders.

[Close]

Online Activities

e01 Using Adjunctive Treatments When First-Line Antidepressants Fail [CME]

Michael E. Thase

[Abstract]

e02 Identifying, Diagnosing, and Managing ADHD in College Students [CME]

Larry Culpepper

[Abstract]

e03 Diagnosing and Managing Patients With Dementia [CME]

Robbie Cooksey and Janice Knebl

[Abstract]

e04 Assessing and Measuring Nonresponse in Schizophrenia [CME]

John M. Kane

[Abstract]

Information for Authors

see www.psychiatrist.com/author.htm

Supplements|Buy a Single Article|Most Popular

The Journal of Clinical Psychiatry is the official journal of the American Society for Clinical Psychopharmacology

Ahead of Print
Current Issue
Forums

JCP Online ForumsJCP Online Forum

View full page

Join the Discussion

Commentary: Depression in Women: Windows of Vulnerability and New Insights Into the Link Between Estrogen and Serotonin Sonali Lokuge, Benicio N. Frey, Jane A. Foster, Claudio N. Soares, and Meir Steiner
[Full Text With Comments]

Does DSM-IV Already Capture the Dimensional Nature of Personality Disorders? Mark Zimmerman, Iwona Chelminski, Diane Young, Kristy Dalrymple and Jennifer Martinez
[Full Text With Comments]

A National Epidemic of Unintentional Prescription Opioid Overdose Deaths: How Physicians Can Help Control It Leonard J. Paulozzi, Richard H. Weisler, and Ashwin A. Patkar
[Full Text With Comments]

Editors’ Perspectives: Peer Review and the Evolving Journal

Commentaries on Peer Review and the Evolving Journal. Marlene P. Freeman
[Full Text With Forum]

Peer Review Perspective for Early Career Psychiatrists. Alan J. Gelenberg
[Full Text With Forum]

Learning to Review. Robert Freedman
[Full Text With Forum]

Peer Review by Early Career Psychiatrists: An Opportunity for Development. Anne F. Gross, Ilse R. Wiechers, and Theodore A. Stern
[Full Text With Forum]

The Evolution of the Psychiatry Research Journal. John H. Krystal
[Full Text With Forum]

Peer Review in Early Career: Just Say Yes! Peter P. Roy-Byrne
[Full Text With Forum]

Perspectives on Perinatal Depression Treatment

Perinatal Psychiatry: The Challenges of Making Rational Treatment Decisions at the Interface of Psychiatry and Obstetrics. Marlene P. Freeman
[Full Text With Forum]

Influence of the Media on Women Taking Antidepressants During Pregnancy. Adrienne Einarson
[Full Text With Forum]

The Other Side of the Risk Equation: Exploring Risks of Untreated Depression and Anxiety in Pregnancy. Ellen M. Markus and Laura J. Miller
[Full Text With Forum]

Reflections on Perinatal Depression Treatment. Bryanne Barnett, and Marie-Paule Austin
[Full Text With Forum]

Do We Scare Because We Care? Diane N. Solomon
[Full Text With Forum]

Perinatal Depression: Searching for Specific Tools for a Closer Look at This Window. Claudio N. Soares, and Meir Steiner
[Full Text With Forum]

Psychotherapeutic Treatment Options for Perinatal Depression: Emphasis on Maternal-Infant Dyadic Outcomes. Maria Muzik, Sheila M. Marcus, and Heather A. Flynn
[Full Text With Forum]

No Decision Is Without Risk. Rita Suri, and Lori L. Altshuler
[Full Text With Forum]

The Cost of Restricting Knowledge. Anna R. Brandon, Geetha Shivakumar, Stephen J. Inrig, Simon J. Craddock Lee, and John Z. Sadler
[Full Text With Forum]

Pharmacotherapy or Untreated Antenatal Depression: A False Dichotomy. Sona Dimidjian, and Michael W. O’Hara
[Full Text With Forum]

 

Online Journal Offerings

| 2012 | 2011 | 2010 |

| 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 |

| 1999 | 1998 | 1997 | 1996 |

Collections

Special Sections

Early Career Psychiatrists

Marlene P. Freeman, MD (Editor)

Focus on Alzheimer's Disease and Related Disorders

Eric M. Reiman, MD (Editor)

Focus on Childhood and Adolescent Mental Health

Karen D. Wagner, MD, PhD (Editor)

Focus on Women's Mental Health

Marlene P. Freeman, MD (Editor)

Features

ASCP Corner

J. Craig Nelson, MD (Editor)

Brainstorms

Stephen M. Stahl, MD, PhD

Case Reports

NCDEU Festschrift

Information from Industry

Product Monograph

Academic Highlights Feature

Optimizing Clinical Outcomes Across Domains of Life in Adolescents and Adults With ADHD

Lenard A. Adler, MD (Chair), et al

Attention-deficit/hyperactivity disorder (ADHD) often persists into adulthood and is associated with significant impairment in multiple domains of life. In this article, receive guidance on assessing for ADHD and get an overview of pharmacologic and nonpharmacologic treatment strategies.

>>See the entire activity

>>See all available Academic Highlights

Supplement Feature

Recent Advances in Treatments for Schizophrenia

John M. Kane, MD (Chair), et al

Read this Supplement to get an overview of the risks and benefits of currently available antipsychotics and to discover the most desirable characteristics of new agents. This information will help you optimize the use of existing antipsychotics, improve individual outcomes, and better evaluate new medications.

>>See the entire supplement

>>See all available supplements

CME

JCP CME

Looking Past First-Line Therapy for Major Depressive Disorder

Larry Culpepper, MD, MPH (Chair), et al

Find out what to do when first-line treatments don’t elicit adequate symptomatic improvement for your patients with depression, including choosing next-step strategies and when and how to implement them.

>>See the entire activity

>>See all Journal CME activities

Multimedia CME

The Appropriate Use of Opiates in Chronic Pain

Autry J. Parker, MD, MPH

New! Review opioid therapy for chronic pain and learn about tools that can help you assess patients for abuse risk and safeguard them during treatment.

>>See the entire activity

>>See all Multimedia activities

Special Feature

Brief Reports: Shift Work Disorder: Overview and Diagnosis

Thomas Roth, PhD

Read this interactive report to better understand the pathophysiology, prevalence, and consequences of shift work disorder and to find out how to diagnose this problem when you encounter it in clinical practice.

>>See the entire activity

>>See all Special Features

Multimedia Curriculum

Learn. Practice. Treat.

Antidepressant Mechanism of Action Effects

Anita H. Clayton, MD

New! Discover how antidepressants work and find out how their mechanisms of action can help you tailor treatments to your patients.

>>See the entire activity

>>See related activities

INFORMATION FOR AUTHORS

Printer-friendly version

Manuscript and Letter Submission

Submit a Manuscript Now

If your manuscript fits within the scope of the journal, we encourage you to submit. Acceptance is contingent on favorable peer review.

Our user-friendly electronic manuscript submission and peer review system allows you to submit your manuscript online securely, conveniently, and instantly. Authors can track the progress of their manuscripts from submission to publication. Assistance is available via e-mail if needed.

First-time submitters will need to register for an account. After you follow the link above for the submission page, select “New authors should register for an account.” Note that this account is separate from the account you use to access Psychiatrist.com and CMEInstitute.com, so even if you are already registered to access our sites (which provides the ability to obtain free CME credit), you will still need to establish an account to use the manuscript submission system.

Journal Statistics and Impact Information (updated October 2007)

Journal Statistics

Acceptance rate

  

31%

No. of articles published per issue

  

Mean=16, range=14–22

Submission-to–first decision time (mean)

  

40.9 days

Submission-to–final decision time (mean)

  

51.6 days

Submission-to-acceptance time (estimated average)

  

4 months

Acceptance-to-publication time

  

Mean=5.2 months,
range=3–9 months

Impact Information

The Journal of Clinical Psychiatry continues to be ranked as the most-read and 6th most-cited psychiatric journal in the world (according to the Focus Readership Study, June 2007, and Citation Index, July 2007, respectively). The Journal mails to about 35,184 recipients,* and over 20,000 allied mental health professionals have requested daily receipt of informational e-mails about our journals and Web CME activities.

The JCP is also a member of BPA Worldwide and is the official journal of the American Society of Clinical Psychopharmacology, which consists of 800 members who are biopsychiatric researchers, academicians, and clinicians.

*Source: BPA Circulation Statement, June 2007

Authorship / Copyright / Disclosure / Acknowledgment Form

See the form in PDF format. At the time of article submission, each author must submit a form incorporating 4 statements: (1) authorship, (2) copyright transfer or federal employment, and (3) financial or other relationships that might pose a conflict of interest. The corresponding author must sign (4) the Acknowledgment statement. This form can be mailed to Physicians Postgraduate Press, P.O. Box 752870, Memphis, TN 38175-2870, faxed to the Production Coordinator at 901-273-2752, or scanned and uploaded during the electronic submission process.

Quick-Reference Checklist for Manuscript Submission

See the checklist.

Guidelines for Authors on Manuscript Preparation and Submission

See the guidelines.

Reprints

Authors receive a complimentary copy of the issue in which their article or letter appears and are sent a reprint order form at the time their article is published.

Authors can also order single copies of articles or back issues, as well as larger quantities of high-quality photocopies or reprints. Learn more about reprints.

Clinical Trials Registration Information

See the clinical trials registration information in our Information for Authors.

Embargo Policy

Material published in the Journal is embargoed until the 15th of the month of issue. Contact .

Helpful Links

 

INFORMATION FOR REVIEWERS

Printer-friendly version

Manuscripts that meet the Journal’s scope and submission criteria are sent to expert consultants for peer review.

Conflict of Interest

Reviewers who have a financial or personal conflict of interest related to a manuscript are obligated to decline the reviewer position.

Processing of Peer Reviews

The peer review process is conducted using the electronic submission system used for manuscripts. Potential reviewers are queried in advance about their availability. While reviewers are asked to complete their reviews within 3 weeks of receiving the manuscript, more expeditious turnaround is highly valued. If you would like to be a peer reviewer, please send your CV to .

Confidentiality

The reviewers' identities are not revealed, and strict confidentiality regarding the submitted manuscript is maintained. Reviewers must not keep copies of the manuscripts they review or discuss any of the information or data with others.

Circle of Honor

Peer review is essential to a medical journal, and each year, those peer reviewers who have carried the heaviest load and reviewed the greatest number of manuscripts are recognized as members of the Journal’s Circle of Honor.

The Circle of Honor is the Journal’s acknowledgment of the indispensable contribution—the dedication, scholarship, and scientific rigor—generously donated by these individuals.

2011 Circle of Honor

David C. Emelity, MD

Scott A. Freeman, MD

Joseph F. Goldberg, MD

John H. Greist, MD

Robert M. A. Hirschfeld, MD

James W. Jefferson, MD

James H. Kocsis, MD

Mario Maj, MD

Roger E. Meyer, MD

Maria A. Oquendo, MD

Michael K. Popkin, MD

Barbara O. Rothbaum, PhD

Anthony J. Rothschild, MD

Erika Saunders, MD

Mark Zimmerman, MD

Authors and Reviewers

Information for Authors
Information for Reviewers

Terms of Use | Privacy Policy | See Full Website
© Copyright 2010 Physicians Postgraduate Press, Inc.
MedFair.com US Patent No. 6847940